FOCUS DAY, an initiative following the first DAY OF THE DIALOGUE

Working towards solutions for simplification

A full day dedicated to dialogue, held behind closed doors and facilitated by Healixia and NIHDI. This focus day follows the first Day of the Dialogue on March 3, 2026.

Building on the trust and open dialogue established there, we will now work together to identify opportunities to make the reimbursement pathway clearer and easier to navigate.

Our goal is to exchange perspectives on which elements are essential for high-quality reimbursement evaluations and to explore ways to simplify applications and reduce workload for everyone involved.

Program of the Day

  • 09:30 - 10:00 - Welcome coffee and registration
  • 10:00 - 10:30 - Introduction and setting the scene
  • 10:30 - 12:30 - Workshop 1st session
  • 12:30 - 13:30 - Lunch
  • 13:30 - 14:15 - Feedback and choose new group
  • 14:15 - 15:15 - Workshop 2nd session
  • 15:15 - 15:30 - Coffee break
  • 15:30 - 16:15 - Feedback
  • 16:15 - 16:30 - Closing and next steps
  • 16:30 - Networking drink

Around the table

Experienced professionals, including:
  • NIHDI
  • Sick funds
  • Patient representatives
  • Healthcare professionals & pharmacists
  • Market access professionals

Practical

  • Limited to approximately 56 participants, balanced across different perspectives and levels of experience
  • Active participation expected; participants join in their personal capacity
  • The Chatham House Rule applies
  • No predefined outcomes or commitments
  • Discussion focused on the content and clarity of reimbursement applications

Why participate?

  • Build on the trust and understanding created during the first Day of the Dialogue
  • Exchange perspectives on what makes a reimbursement application clear and useful for evaluation
  • Contribute towards mutual understanding on what is essential for evaluations
  • Help identify common ground as a basis for practical improvements

About FOCUS DAY, an initiative following the first DAY OF THE DIALOGUE